Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)

NCT06483737 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Overt Hepatic Encephalopathy

Interventions

DRUG: Human albumin infusion at a modified dosage
DRUG: Human albumin infusion at a routine dosage
DRUG: Lactulose
DRUG: Rifaximin
DRUG: Ornithine Aspartate
DRUG: Branched-Chain Amino Acids
DRUG: Arginine

Sponsor

General Hospital of Shenyang Military Region